| 2025-12-13 |
详情>>
内部人交易：
Weigensberg Arye等共交易3笔
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本38289.33万股
变动原因 ▼▲
- 原因：
- From June 30, 2025 to September 30, 2025
Activities relating to share-based compensation
Share repurchases
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.02美元,归母净利润-763.1万美元,同比去年增长-188.07%
|
| 2025-11-06 |
财报披露：
美东时间 2025-11-06 盘前发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-0.09美元,归母净利润-3358.9万美元,同比去年增长-205.41%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益0.02美元,归母净利润612.20万美元,同比去年增长373.18%
|
| 2025-04-25 |
股东大会：
将于2025-06-20召开股东大会
会议内容 ▼▲
- 1.The receipt of the audited consolidated financial statements of the Company as at and for the fiscal year ended December 31, 2024 and the auditors’ reports thereon;
2.The election to the board of directors of the Company (the “Board of Directors”) of the seven directors named in the attached Proxy Statement;
3.The adoption of an advisory (non-binding) resolution to approve the compensation of the Company’s named executive officers as disclosed in the attached Proxy Statement;
4.The appointment of Davidson & Company LLP (“D&CO”) to serve as the Company’s independent auditor for the fiscal year ending December 31, 2025 and to authorize the Board of Directors to fix D&CO’s remuneration;
5.Such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2025-04-25 |
股东大会：
将于2025-06-20召开股东大会
会议内容 ▼▲
- 1.The receipt of the audited consolidated financial statements of the Company as at and for the fiscal year ended December 31, 2024 and the auditors’ reports thereon;
2.The election to the board of directors of the Company (the “Board of Directors”) of the seven directors named in the attached Proxy Statement;
3.The adoption of an advisory (non-binding) resolution to approve the compensation of the Company’s named executive officers as disclosed in the attached Proxy Statement;
4.The appointment of Davidson & Company LLP (“D&CO”) to serve as the Company’s independent auditor for the fiscal year ending December 31, 2025 and to authorize the Board of Directors to fix D&CO’s remuneration;
5.Such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益-0.45美元,归母净利润-1.69亿美元,同比去年增长57.40%
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益0.11美元,归母净利润4108.00万美元,同比去年增长155.54%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.01美元,归母净利润-264.9万美元,同比去年增长90.92%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.03美元,归母净利润-1099.8万美元,同比去年增长60.05%
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益-0.07美元,归母净利润-2752.9万美元,同比去年增长47.92%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.01美元,归母净利润-224.1万美元,同比去年增长88.31%
|
| 2024-04-26 |
股东大会：
将于2024-06-20召开股东大会
会议内容 ▼▲
- 1.The receipt of the audited consolidated financial statements of the Company as at and for the fiscal year ended December 31, 2023 and the auditors’ reports thereon;
2.The election to the board of directors of the Company (the “Board of Directors”) of the seven directors named in the attached Proxy Statement;
3.The adoption of an advisory (non-binding) resolution to approve the compensation of the Company’s named executive officers as disclosed in the attached Proxy Statement;
4.The appointment of the Company’s independent registered public accounting firm to serve as the Company’s independent auditor for the fiscal year ending December 31, 2024 and to authorize the Board of Directors to fix the independent auditor’s remuneration;
5.The approval of any adjournment of the Annual Meeting to a later date to be determined by the Chair of the Annual Meeting, if necessary, to permit the Company to complete the search for a successor auditor;
6.Such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-0.19美元,归母净利润-7396.3万美元,同比去年增长56.17%
|
| 2023-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.08美元,归母净利润-2917.3万美元,同比去年增长67.53%
|
| 2023-07-07 |
复牌提示：
2023-07-06 14:48:25 停牌，复牌日期 2023-07-06 14:53:25
|
| 2023-04-28 |
股东大会：
将于2023-06-22召开股东大会
会议内容 ▼▲
- 1.The receipt of the audited consolidated financial statements of the Company as at and for the fiscal year ended December 31, 2022 and the auditors’ reports thereon;
2.The election to the board of directors of the Company (the “Board of Directors”) of the seven directors named in the attached Proxy Statement;
3.The adoption of an advisory (non-binding) resolution to approve the compensation of the Company’s named executive officers as disclosed in the attached Proxy Statement;
4.The appointment of KPMG LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 and to authorize the Board of Directors to fix KPMG LLP’s remuneration;
5.Such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-04-29 |
股东大会：
将于2022-06-23召开股东大会
会议内容 ▼▲
- 1.the receipt of the audited consolidated financial statements of the Company as at and for the fiscal year ended December 31, 2021 and the auditors’ reports thereon;
2.the election to the board of directors of the Company (the “Board of Directors”) of the seven directors named in the attached Proxy Statement;
3.the adoption of an advisory (non-binding) resolution to approve the compensation of the Company’s named executive officers as disclosed in the attached Proxy Statement;
4.the appointment of KPMG LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 and to authorize the Board of Directors to fix KPMG LLP’s remuneration;
5.such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-27 |
股东大会：
将于2021-06-25召开股东大会
会议内容 ▼▲
- 1.the receipt of the audited consolidated financial statements of the Company as at and for the fiscal year ended December 31, 2020 and the auditors’ reports thereon;
2.the election to the board of directors of the Company (the “Board of Directors”) of the seven directors named in the attached Proxy Statement;
3.the adoption of an advisory (non-binding) resolution on the compensation of the Company’s named executive officers as disclosed in the attached Proxy Statement;
4.the appointment of KPMG LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 and to authorize the Board of Directors to fix KPMG LLP’s remuneration;
5.such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-04-28 |
股东大会：
将于2020-06-25召开股东大会
会议内容 ▼▲
- 1.the receipt of the audited consolidated financial statements of the Company as at and for the fiscal year ended December 31, 2019 and the auditors’ reports thereon;
2.the election to the board of directors of the Company (the “Board of Directors”) of the seven directors named in the attached Proxy Statement;
3.the adoption of an advisory (non-binding) resolution on the compensation of the Company’s named executive officers as disclosed in the attached Proxy Statement;
4.the adoption of an advisory (non-binding) resolution on the frequency of future “say on pay” votes as described in the attached Proxy Statement;
5.the adoption of an ordinary resolution approving the 2020 Omnibus Equity Incentive Plan of the Company, as described in the attached Proxy Statement;
6.the adoption of a special resolution (the “Continuance Resolution”) authorizing the Company to make an application for the continuance (the “Continuance”) of the Company from the laws of the Province of Ontario to the laws of the Province of British Columbia and approving the notice of articles and articles of the continued company, as described in the attached Proxy Statement;
7.the appointment of KPMG LLP to serve as the independent registered public accounting firm for the fiscal year ending December 31, 2020 and to authorize the Board of Directors to fix KPMG LLP’s remuneration;
8.such other business as may properly come before the Annual and Special Meeting or any adjournments or postponements thereof.
|
| 2019-05-28 |
股东大会：
将于2019-06-19召开股东大会
会议内容 ▼▲
- 1.to receive the audited consolidated financial statements of the Company as at and for the year ended December 31, 2018 and the auditors’ report thereon;
2.to elect the directors of the Company for the following year;
3.to appoint KPMG LLP as the auditors of the Company for the following year and to authorize the board of directors of the Company to fix their remuneration;
4.to transact such further or other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2019-01-18 |
股东大会：
将于2019-02-21召开股东大会
会议内容 ▼▲
- 1.to elect, conditional upon and effective as of the closing of the transactions contemplated by the subscription agreement (the “Subscription Agreement”), dated as of December 7, 2018, by and among the Company, Altria Summit LLC (the “Purchaser”), a wholly owned subsidiary of Altria Group, Inc. (“Altria”) and, solely for certain limited purposes set forth therein, Altria, Kevin C. Crosthwaite Jr., Bronwen Evans, Murray R. Garnick and Bruce A. Gates (the “Altria Nominees”), as directors of the Company, each to hold office until the close of the next annual meeting of Shareholders or until his or her successor has been duly elected and/or appointed and qualified or until his or her earlier death, resignation or removal pursuant to the articles of incorporation of the Company (as amended) and by-laws of the Company (as amended), the investor rights agreement contemplated by the Subscription Agreement, and applicable law, as more particularly described in the management information circular dated as of December 31, 2018 (the “Circular”) accompanying this notice of Meeting;
2.to consider and, if thought advisable, to pass, with or without variation, an ordinary resolution, the full text of which is set forth in Schedule A to the accompanying Circular, approving the transactions contemplated by the Subscription Agreement, whereby, among other things, the Company will issue to the Purchaser, in a private placement transaction: (i) 146,220,892 Shares (subject to adjustment in accordance with the terms of the Subscription Agreement); and (ii) one warrant (the “Warrant”) of the Company (which may be exercised in full or in part at any time and from time to time) entitling the holder thereof, upon the valid exercise in full thereof, to acquire, accept and receive from the Company an aggregate of 72,207,848 Shares (subject to adjustment in accordance with the terms of the Subscription Agreement and with the terms and conditions of the warrant certificate representing and evidencing the Warrant), as more particularly described in the accompanying Circular;
3.to transact such further or other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2018-05-29 |
股东大会：
将于2018-06-28召开股东大会
会议内容 ▼▲
- 1.to receive the audited consolidated financial statements of the Company as at and for the year ended December 31, 2017 and auditors’ report thereon;
2.to elect the directors of the Company for the following year;
3.to appoint KPMG LLP as the auditors of the Company for the following year and to authorize the board of directors of the Company to fix their remuneration;
4.to consider, and if thought advisable to pass, with or without variation, an ordinary resolution to ratify and confirm the repeal of By-law No. 3 and By-law No. 4 of the Company, and the adoption of a new general by-law for the Company, being By-law No. 5, as more particularly described in the management information circular of the Company dated May 28, 2018 (the “Circular”) accompanying this Notice of Meeting;
5.to consider, and if thought advisable to pass, with or without variation, an ordinary resolution to approve the adoption of a new stock option plan of the Company, as more particularly described in the Circular;
6.to transact such further or other business as may properly come before the Meeting or any adjournment or postponement thereof.
|